Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C88 - Spinocerebellar and Spastic Ataxias: Diagnosis and Management

Tuesday 04/05/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Oksana Suchowersky, MD, FAAN
Movement Disorders
Participants should become familiar with the differential diagnoses, work-up, and management of patients with spinocerebellar and spastic ataxias with particular attention to genetic testing, update on pathophysiology, and potential for new and genetic therapies.
 
2.00 CME credits
Patient Care & Procedural Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:40 AM PDT Speaker Clinical and Genetic Aspects of the SCAs and Spastic Ataxias
Oksana Suchowersky, MD, FAAN
07:00 AM - 07:00 AM PDT Speaker Walk-in Slides
Oksana Suchowersky, MD, FAAN
07:40 AM - 08:20 AM PDT Speaker Pathogenetics and Potential Treatments
Guy A. Rouleau, MD, PhD
08:20 AM - 08:45 AM PDT Discussion Case Presentations
Oksana Suchowersky, MD, FAAN, Guy A. Rouleau, MD, PhD
08:45 AM - 09:00 AM PDT Q&A Questions and Answers
Oksana Suchowersky, MD, FAAN, Guy A. Rouleau, MD, PhD
Faculty Disclosures
Oksana Suchowersky, MD, FAAN Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Guy A. Rouleau, MD, PhD Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.